RAD52 Primary Antibody
|Formulation||Purified antibody in PBS with 0.05% sodium azide|
|Immunogen||Purified recombinant fragment of human RAD52 (AA: 269-418) expressed in E. Coli.|
|Shipping Information||This product will ship in a box containing blue ice at a temperature of 4°C. Learn More|
|ICC (Immunocytochemistry)||1/200 - 1/1000|
|FCM (Flow Cytometry)||1/200 - 1/400|
|WB (Western Blot)||1/500 - 1/2000|
Figure 1: Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Figure 2:Western blot analysis using RAD52 mAb against human RAD52 (AA: 269-418) recombinant protein. (Expected MW is 42.5 kDa)
Figure 3:Western blot analysis using RAD52 mAb against HEK293 (1) and RAD52 (AA: 269-418)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 4:Western blot analysis using RAD52 mouse mAb against HepG2 (1), MCF-7 (2), MCF-7 (3), and C6 (4) cell lysate.
Figure 5:Immunofluorescence analysis of HeLa cells using RAD52 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Figure 6:Flow cytometric analysis of MCF7 cells using RAD52 mouse mAb (green) and negative control (red).
|Description||The protein encoded by this gene shares similarity with Saccharomyces cerevisiae Rad52, a protein important for DNA double-strand break repair and homologous recombination. This gene product was shown to bind single-stranded DNA ends, and mediate the DNA-DNA interaction necessary for the annealing of complementary DNA strands. It was also found to interact with DNA recombination protein RAD51, which suggested its role in RAD51 related DNA recombination and repair. A pseudogene of this gene is present on chromosome 2. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known.|
|References (references)||1.Blood. 2013 Aug 15;122(7):1293-304. |
2.PLoS One. 2012;7(11):e50461.